Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
GEN vs CHKP vs IDXX vs PANW vs FTNT
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Medical - Diagnostics & Research
Software - Infrastructure
Software - Infrastructure
GEN vs CHKP vs IDXX vs PANW vs FTNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Software - Infrastructure | Medical - Diagnostics & Research | Software - Infrastructure | Software - Infrastructure |
| Market Cap | $12.23B | $12.05B | $45.45B | $138.16B | $79.89B |
| Revenue (TTM) | $5.00B | $2.76B | $4.45B | $9.89B | $7.11B |
| Net Income (TTM) | $973M | $1.06B | $1.10B | $1.28B | $1.95B |
| Gross Margin | 78.5% | 85.0% | 62.1% | 73.5% | 80.7% |
| Operating Margin | 42.4% | 29.8% | 31.6% | 14.4% | 31.1% |
| Forward P/E | 7.9x | 11.1x | 39.5x | 53.3x | 36.3x |
| Total Debt | $8.20B | $1.97B | $1.08B | $338M | $996M |
| Cash & Equiv. | $411M | $1.80B | $180M | $2.27B | $2.50B |
GEN vs CHKP vs IDXX vs PANW vs FTNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gen Digital Inc. (GEN) | 100 | 88.6 | -11.4% |
| Check Point Softwar… (CHKP) | 100 | 105.4 | +5.4% |
| IDEXX Laboratories,… (IDXX) | 100 | 185.2 | +85.2% |
| Palo Alto Networks,… (PANW) | 100 | 501.2 | +401.2% |
| Fortinet, Inc. (FTNT) | 100 | 387.8 | +287.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GEN vs CHKP vs IDXX vs PANW vs FTNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GEN carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 27.1%, EPS growth 52.4%, 3Y rev CAGR 14.7%
- 27.1% revenue growth vs CHKP's 6.3%
- Lower P/E (7.9x vs 53.3x)
- 2.5% yield; 1-year raise streak; the other 4 pay no meaningful dividend
CHKP is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- beta 0.36
- Lower volatility, beta 0.36, Low D/E 68.4%, current ratio 2.05x
- Beta 0.36, current ratio 2.05x
- 38.4% margin vs PANW's 13.0%
IDXX ranks third and is worth considering specifically for momentum and efficiency.
- +17.6% vs CHKP's -47.7%
- 32.6% ROA vs PANW's 5.1%, ROIC 42.5% vs 17.1%
PANW lags the leaders in this set but could rank higher in a more targeted comparison.
FTNT is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 15.8% 10Y total return vs PANW's 7.5%
- PEG 1.09 vs GEN's 2.90
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% revenue growth vs CHKP's 6.3% | |
| Value | Lower P/E (7.9x vs 53.3x) | |
| Quality / Margins | 38.4% margin vs PANW's 13.0% | |
| Stability / Safety | Beta 0.36 vs IDXX's 1.35 | |
| Dividends | 2.5% yield; 1-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +17.6% vs CHKP's -47.7% | |
| Efficiency (ROA) | 32.6% ROA vs PANW's 5.1%, ROIC 42.5% vs 17.1% |
GEN vs CHKP vs IDXX vs PANW vs FTNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
GEN vs CHKP vs IDXX vs PANW vs FTNT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GEN leads in 1 of 6 categories
PANW leads 1 • CHKP leads 0 • IDXX leads 0 • FTNT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — GEN and CHKP each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PANW is the larger business by revenue, generating $9.9B annually — 3.6x CHKP's $2.8B. CHKP is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to PANW's 13.0%. On growth, GEN holds the edge at +27.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5.0B | $2.8B | $4.4B | $9.9B | $7.1B |
| EBITDAEarnings before interest/tax | $2.5B | $909M | $1.5B | $1.9B | $2.3B |
| Net IncomeAfter-tax profit | $973M | $1.1B | $1.1B | $1.3B | $2.0B |
| Free Cash FlowCash after capex | $1.5B | $1.3B | $845M | $4.1B | $2.4B |
| Gross MarginGross profit ÷ Revenue | +78.5% | +85.0% | +62.1% | +73.5% | +80.7% |
| Operating MarginEBIT ÷ Revenue | +42.4% | +29.8% | +31.6% | +14.4% | +31.1% |
| Net MarginNet income ÷ Revenue | +19.5% | +38.4% | +24.6% | +13.0% | +27.5% |
| FCF MarginFCF ÷ Revenue | +29.9% | +47.5% | +19.0% | +41.1% | +34.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +27.0% | +4.8% | +14.3% | +14.9% | +20.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.7% | +5.8% | +16.6% | +57.9% | +28.6% |
Valuation Metrics
GEN leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 12.0x trailing earnings, CHKP trades at a 90% valuation discount to PANW's 122.8x P/E. Adjusting for growth (PEG ratio), GEN offers better value at 1.14x vs IDXX's 3.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $12.2B | $12.0B | $45.4B | $138.2B | $79.9B |
| Enterprise ValueMkt cap + debt − cash | $20.0B | $12.2B | $46.3B | $136.2B | $78.4B |
| Trailing P/EPrice ÷ TTM EPS | 12.86x | 12.01x | 43.75x | 122.83x | 44.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.92x | 11.07x | 39.45x | 53.30x | 36.28x |
| PEG RatioP/E ÷ EPS growth rate | 1.14x | 1.20x | 3.06x | — | 1.34x |
| EV / EBITDAEnterprise value multiple | 9.44x | 13.22x | 31.60x | 85.88x | 35.09x |
| Price / SalesMarket cap ÷ Revenue | 2.45x | 4.42x | 10.56x | 14.98x | 11.75x |
| Price / BookPrice ÷ Book value/share | 4.79x | 4.41x | 28.75x | 17.82x | 65.26x |
| Price / FCFMarket cap ÷ FCF | 8.03x | 9.97x | 43.14x | 39.82x | 35.89x |
Profitability & Efficiency
Evenly matched — IDXX and PANW each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
FTNT delivers a 155.7% return on equity — every $100 of shareholder capital generates $156 in annual profit, vs $14 for PANW. PANW carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEN's 3.14x. On the Piotroski fundamental quality scale (0–9), GEN scores 7/9 vs PANW's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +39.9% | +36.4% | +70.9% | +13.6% | +155.7% |
| ROA (TTM)Return on assets | +6.1% | +15.8% | +32.6% | +5.1% | +19.4% |
| ROICReturn on invested capital | +15.9% | +23.2% | +42.5% | +17.1% | — |
| ROCEReturn on capital employed | +16.6% | +17.2% | +61.4% | +8.9% | +37.7% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 7 | 4 | 7 |
| Debt / EquityFinancial leverage | 3.14x | 0.68x | 0.67x | 0.04x | 0.81x |
| Net DebtTotal debt minus cash | $7.8B | $172M | $897M | -$1.9B | -$1.5B |
| Cash & Equiv.Liquid assets | $411M | $1.8B | $180M | $2.3B | $2.5B |
| Total DebtShort + long-term debt | $8.2B | $2.0B | $1.1B | $338M | $996M |
| Interest CoverageEBIT ÷ Interest expense | 4.15x | — | 35.55x | 1559.00x | 214.35x |
Total Returns (Dividends Reinvested)
PANW leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PANW five years ago would be worth $34,443 today (with dividends reinvested), compared to $9,640 for CHKP. Over the past 12 months, IDXX leads with a +17.6% total return vs CHKP's -47.7%. The 3-year compound annual growth rate (CAGR) favors PANW at 27.1% vs CHKP's -1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -22.1% | -36.2% | -14.6% | +9.6% | +38.6% |
| 1-Year ReturnPast 12 months | -25.7% | -47.7% | +17.6% | +4.5% | +1.2% |
| 3-Year ReturnCumulative with dividends | +27.2% | -5.6% | +17.9% | +105.2% | +63.4% |
| 5-Year ReturnCumulative with dividends | +7.5% | -3.6% | +5.1% | +244.4% | +154.9% |
| 10-Year ReturnCumulative with dividends | +119.3% | +40.1% | +556.2% | +746.7% | +1584.4% |
| CAGR (3Y)Annualised 3-year return | +8.4% | -1.9% | +5.6% | +27.1% | +17.8% |
Risk & Volatility
Evenly matched — CHKP and FTNT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CHKP is the less volatile stock with a 0.36 beta — it tends to amplify market swings less than IDXX's 1.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. FTNT currently trades 96.1% from its 52-week high vs CHKP's 49.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.36x | 1.35x | 1.02x | 1.02x |
| 52-Week HighHighest price in past year | $32.22 | $233.78 | $769.98 | $223.61 | $112.39 |
| 52-Week LowLowest price in past year | $17.78 | $112.23 | $471.74 | $139.57 | $70.12 |
| % of 52W HighCurrent price vs 52-week peak | +62.7% | +49.4% | +74.3% | +87.9% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 30.3 | 52.1 | 61.6 | 64.3 |
| Avg Volume (50D)Average daily shares traded | 6.4M | 1.3M | 533K | 7.5M | 5.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: GEN as "Buy", CHKP as "Hold", IDXX as "Buy", PANW as "Buy", FTNT as "Hold". Consensus price targets imply 58.5% upside for GEN (target: $32) vs -19.6% for FTNT (target: $87). GEN is the only dividend payer here at 2.50% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $32.00 | $153.94 | $773.13 | $207.85 | $86.81 |
| # AnalystsCovering analysts | 21 | 63 | 22 | 86 | 68 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | — |
| Dividend / ShareAnnual DPS | $0.50 | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +5.2% | +11.6% | +2.7% | 0.0% | +2.9% |
GEN leads in 1 of 6 categories (Valuation Metrics). PANW leads in 1 (Total Returns). 3 tied.
GEN vs CHKP vs IDXX vs PANW vs FTNT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GEN or CHKP or IDXX or PANW or FTNT a better buy right now?
For growth investors, Gen Digital Inc.
(GEN) is the stronger pick with 27. 1% revenue growth year-over-year, versus 6. 3% for Check Point Software Technologies Ltd. (CHKP). Check Point Software Technologies Ltd. (CHKP) offers the better valuation at 12. 0x trailing P/E (11. 1x forward), making it the more compelling value choice. Analysts rate Gen Digital Inc. (GEN) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GEN or CHKP or IDXX or PANW or FTNT?
On trailing P/E, Check Point Software Technologies Ltd.
(CHKP) is the cheapest at 12. 0x versus Palo Alto Networks, Inc. at 122. 8x. On forward P/E, Gen Digital Inc. is actually cheaper at 7. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fortinet, Inc. wins at 1. 09x versus Gen Digital Inc. 's 2. 90x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — GEN or CHKP or IDXX or PANW or FTNT?
Over the past 5 years, Palo Alto Networks, Inc.
(PANW) delivered a total return of +244. 4%, compared to -3. 6% for Check Point Software Technologies Ltd. (CHKP). Over 10 years, the gap is even starker: FTNT returned +1584% versus CHKP's +40. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GEN or CHKP or IDXX or PANW or FTNT?
By beta (market sensitivity over 5 years), Check Point Software Technologies Ltd.
(CHKP) is the lower-risk stock at 0. 36β versus IDEXX Laboratories, Inc. 's 1. 35β — meaning IDXX is approximately 276% more volatile than CHKP relative to the S&P 500. On balance sheet safety, Palo Alto Networks, Inc. (PANW) carries a lower debt/equity ratio of 4% versus 3% for Gen Digital Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GEN or CHKP or IDXX or PANW or FTNT?
By revenue growth (latest reported year), Gen Digital Inc.
(GEN) is pulling ahead at 27. 1% versus 6. 3% for Check Point Software Technologies Ltd. (CHKP). On earnings-per-share growth, the picture is similar: Gen Digital Inc. grew EPS 52. 4% year-over-year, compared to -56. 0% for Palo Alto Networks, Inc.. Over a 3-year CAGR, PANW leads at 18. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GEN or CHKP or IDXX or PANW or FTNT?
Check Point Software Technologies Ltd.
(CHKP) is the more profitable company, earning 38. 8% net margin versus 12. 3% for Palo Alto Networks, Inc. — meaning it keeps 38. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEN leads at 42. 4% versus 13. 5% for PANW. At the gross margin level — before operating expenses — CHKP leads at 85. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GEN or CHKP or IDXX or PANW or FTNT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fortinet, Inc. (FTNT) is the more undervalued stock at a PEG of 1. 09x versus Gen Digital Inc. 's 2. 90x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Gen Digital Inc. (GEN) trades at 7. 9x forward P/E versus 53. 3x for Palo Alto Networks, Inc. — 45. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GEN: 58. 5% to $32. 00.
08Which pays a better dividend — GEN or CHKP or IDXX or PANW or FTNT?
In this comparison, GEN (2.
5% yield) pays a dividend. CHKP, IDXX, PANW, FTNT do not pay a meaningful dividend and should not be held primarily for income.
09Is GEN or CHKP or IDXX or PANW or FTNT better for a retirement portfolio?
For long-horizon retirement investors, Fortinet, Inc.
(FTNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +1584% 10Y return). Both have compounded well over 10 years (FTNT: +1584%, IDXX: +556. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GEN and CHKP and IDXX and PANW and FTNT?
These companies operate in different sectors (GEN (Technology) and CHKP (Technology) and IDXX (Healthcare) and PANW (Technology) and FTNT (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GEN is a mid-cap high-growth stock; CHKP is a mid-cap deep-value stock; IDXX is a mid-cap quality compounder stock; PANW is a mid-cap quality compounder stock; FTNT is a mid-cap quality compounder stock. GEN pays a dividend while CHKP, IDXX, PANW, FTNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.